Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

IGC Pharma (IGC) Depreciation & Amortization (IS) (2016 - 2017)

IGC Pharma (IGC) has disclosed Depreciation & Amortization (IS) for 5 consecutive years, with $4989.0 as the latest value for Q4 2017.

  • Quarterly Depreciation & Amortization (IS) fell 97.46% to $4989.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$180806.0 through Dec 2017, down 126.89% year-over-year, with the annual reading at $195514.0 for FY2017, 73.17% down from the prior year.
  • Depreciation & Amortization (IS) for Q4 2017 was $4989.0 at IGC Pharma, up from $4344.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (IS) was $323778.0 in Q1 2015, with the low at -$196103.0 in Q1 2017.
  • Average Depreciation & Amortization (IS) over 5 years is $126885.9, with a median of $148352.5 recorded in 2013.
  • The sharpest move saw Depreciation & Amortization (IS) skyrocketed 37.13% in 2016, then crashed 169.85% in 2017.
  • Over 5 years, Depreciation & Amortization (IS) stood at $147708.0 in 2013, then grew by 4.07% to $153725.0 in 2014, then decreased by 6.98% to $143000.0 in 2015, then soared by 37.13% to $196103.0 in 2016, then tumbled by 97.46% to $4989.0 in 2017.
  • According to Business Quant data, Depreciation & Amortization (IS) over the past three periods came in at $4989.0, $4344.0, and $5964.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.